Young researchers who left the academic path to transform their bright ideas into thriving companies discuss their experiences, and how you can launch your own business.
The Scientist
Most Recent
Founder, Chairman, and CEO, NeuroVigil, Age: 33
After decades of political wrangling, the European Union is poised to introduce a single patent system to reduce red tape and application costs for researchers and companies.
An Israeli company plans to synthesize DNA on demand for anyone, including those outside of research labs.
Two lawsuits against prominent researcher Craig Thompson for allegedly failing to share intellectual property with his institution lead to a licensing agreement on cancer diagnostics.
Critics point out that cell therapy has yet to top existing treatments. Biotech companies are setting out to change that—and prove that the technology can revolutionize medicine.
An Amgen executive refutes accusations that the company published misleading results of its mid-90s clinical trial testing an anemia drug.
Much has changed in the 10 years since our first survey of industry researchers. Large companies are now looking to small, nimble ones for services as well as innovation.
A NJ senator and BIO are beating the drum to reinstitute a law that would channel millions into small life science companies around the country.
A former Sanofi research scientist is sentenced to 18 months in prison for stealing trade secrets.
Follow The Scientist
Advertisement
Stay Connected with The Scientist
-
The Scientist Magazine
-
The Scientist Careers
-
Neuroscience Research Techniques
-
Genetic Research Techniques
-
Cell Culture Techniques
-
Microbiology and Immunology
-
Cancer Research and Technology
Current Issue
